A recent Psychiatry digest,
as sent to subscribers

Study Type: Genetic association study (case-cohort design)

Key Question: How do recurrent copy number variants (rCNVs) and polygenic scores (PGSs) independently and jointly contribute to psychiatric disorder risk?

Key Findings:

• rCNV carriage significantly increased risk for ASD (β=0.33), ADHD (β=0.29), and schizophrenia spectrum disorders (β=0.25) but not major depression
• PGSs identified more at-risk individuals than rCNVs at comparable absolute risk levels, except for ASD
• Negative interactions observed between some rCNVs and PGSs (e.g., 16p13.11 duplication and ADHD-PGS), suggesting PGSs may attenuate rCNV-associated risk in certain cases

Clinical Relevance: This supports using both genetic markers complementarily in psychiatric risk assessment, potentially informing early intervention strategies and genetic counselling in NHS services.

Limitations: Study limited to European-ancestry individuals from Danish population, which may limit generalisability to UK's diverse population.

Study Type: Narrative review

Key Question: What strategies beyond diagnostic cutoffs can be used to establish clinical decision thresholds for continuous psychopathology measures in psychiatric practice?

Key Findings:

• Four threshold strategies identified: statistical deviance from population norms (used in neuropsychology/child psychiatry), functional impairment reference points, probability of negative outcomes (common in internal medicine), and cost-benefit analysis (emerging in European psychiatry)
• Diagnosis-focused thresholds may be inadequate for many clinical decisions including selective prevention and treatment selection
• Three of the four strategies require stakeholder input due to inherent value judgments in threshold selection

Clinical Relevance: This addresses a fundamental gap in UK psychiatric practice where continuous symptom measures need translation into actionable clinical decisions for treatment initiation, resource allocation, and risk management beyond traditional diagnostic frameworks.

Limitations: As a narrative review, it provides conceptual framework rather than empirical evidence for the effectiveness of these alternative threshold strategies in clinical practice.

Study Type: Genetic association study using trio models across three cohorts

Key Question: Is the observed association between maternal dietary patterns during pregnancy and offspring ADHD due to causal effects or genetic confounding?

Key Findings:

• Initial COPSAC2010 cohort (N=437 trios) suggested maternal healthy dietary pattern polygenic scores were associated with reduced offspring ADHD traits after adjusting for child and paternal genetics
• Findings were not replicated in larger MoBa (N=41,580) and ALSPAC (N=1,211) cohorts, where results suggested genetic confounding rather than causal effects
• Overall evidence does not support a robust causal pathway from maternal pregnancy diet to offspring ADHD

Clinical Relevance: This challenges observational evidence linking maternal diet to offspring ADHD risk, suggesting genetic factors may confound this relationship rather than diet having direct causal effects.

Limitations: Dietary pattern polygenic scores had limited predictive power, explaining only a small proportion of actual pregnancy diet variance.

Study Type: Case-control study

Key Question: Can elevated urinary microbially-derived metabolites (MDMs) serve as a diagnostic screening test for autism spectrum disorder in children?

Key Findings:

• Children with ASD (n=52) had significantly higher urinary concentrations of multiple MDMs compared to typically developing controls (n=47), with levels sometimes 100-1000× higher
• Classification using one or more elevated MDMs achieved 90% sensitivity and 100% specificity for ASD diagnosis
• 90% of children with ASD had at least one MDM above any control level (average of 3 elevated MDMs per child vs 0 in controls)

Clinical Relevance: This proposes a potential objective laboratory-based screening tool for ASD that could complement clinical assessment, though would require validation in UK populations before NHS implementation.

Limitations: Small sample size and single study design require replication in larger, independent cohorts before clinical application.

Study Type: Meta-analysis of functional neuroimaging studies

Key Question: What are the consistent patterns of brain activity alterations in panic disorder beyond traditional fear circuits?

Key Findings:

• Increased activity identified in a prefrontal-hippocampus-brainstem axis extending beyond canonical fear regions
• Strong spatial associations found with serotonergic and dopaminergic receptor distributions
• Gene expression profiles of candidate genes explained over one-third of variance in brain activity patterns, supporting a polygenic model

Clinical Relevance: Suggests panic disorder involves widespread neural alterations beyond fear circuitry, potentially informing broader therapeutic targets and explaining high treatment resistance rates commonly encountered in NHS practice.

Limitations: Meta-analysis methodology may be limited by heterogeneity between included neuroimaging studies and potential publication bias.

Study Type: Cross-sectional fMRI study

Key Question: How do anxiety sensitivity and intolerance of uncertainty relate to distinct neural mechanisms underlying avoidance behaviour in anxiety-related disorders?

Key Findings:

• In 58 adults with anxiety-related disorders vs 77 healthy controls, anxiety sensitivity strengthened the relationship between anterior insula threat reactivity and maladaptive avoidance behaviour
• Higher intolerance of uncertainty was associated with reduced concordance between avoidance behaviour and neural activity in motor cortex/intraparietal sulcus during mental simulation
• These two transdiagnostic factors (anxiety sensitivity and intolerance of uncertainty) appear to influence avoidance through separate neural pathways

Clinical Relevance: This suggests that targeting anxiety sensitivity versus intolerance of uncertainty may require different therapeutic approaches in UK NHS anxiety disorder services, potentially informing personalised treatment selection.

Limitations: Cross-sectional design prevents causal inference about the relationship between these psychological constructs and neural mechanisms.

Study Type: Systematic review and meta-analysis

Key Question: What peripheral blood cytokine profiles distinguish autistic from non-autistic individuals?

Key Findings:

• Meta-analysis of 98 studies (4,236 autistic vs 3,333 controls) found significantly elevated pro-inflammatory cytokines in autism: IL-1β (g=0.620), IL-6 (g=0.365), IL-8 (g=0.384), TNF-α (g=0.31), and IFN-γ (g=0.404)
• Anti-inflammatory IL-4 was also elevated (g=0.245), suggesting mixed inflammatory profile
• No association found between cytokine levels and autism trait severity within autistic populations

Clinical Relevance: These findings may inform understanding of immune dysfunction in autism and could potentially guide future biomarker development or anti-inflammatory treatment approaches in UK autism services.

Limitations: Over one-third of included studies had high risk of bias, limiting confidence in conclusions.

Study Type: Experimental study combining genomic analysis, cell culture experiments, and animal model validation

Key Question: How do multiple genes at the 11p11.2 locus work together to contribute to Alzheimer's disease pathogenesis?

Key Findings:

• Three genes (MTCH2, NDUFS3, PSMC3) showed coordinated down-regulation in AD patients and mouse models, synergistically increasing mitochondrial ROS and activating caspase-7-mediated apoptosis
• Pharmacological caspase inhibition with Q-VD-OPh improved memory deficits and reduced amyloid plaque burden in APP/PS1 mice
• Individual gene knockdowns affected mitochondrial function, but combined effects were greater than individual contributions

Clinical Relevance: This identifies a novel polygenic mechanism in Alzheimer's disease that could inform therapeutic targets, particularly caspase inhibition strategies for neuroprotection in UK memory services.

Limitations: Findings are primarily from cell culture and mouse models, requiring validation in human post-mortem tissue and clinical populations.